Literature DB >> 26485079

Antibiotics: Synergistic MRSA combinations.

Karen Bush1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26485079     DOI： 10.1038/nchembio.1935

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN： 1552-4450            Impact factor:   15.040


× No keyword cloud information.
  8 in total

1.  Antagonism of chemical genetic interaction networks resensitize MRSA to β-lactam antibiotics.

Authors:  Sang Ho Lee; Lisa Wang Jarantow; Hao Wang; Susan Sillaots; Henry Cheng; Timothy C Meredith; John Thompson; Terry Roemer
Journal:  Chem Biol       Date:  2011-11-23

2.  In vitro synergistic activity between meropenem and other beta-lactams against methicillin-resistant Staphylococcus aureus.

Authors:  Y Sumita; S Mitsuhashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

3.  The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.

Authors:  G Seibert; D Isert; N Klesel; M Limbert; A Markus; E Schrinner
Journal:  J Antimicrob Chemother       Date:  1992-04       Impact factor: 5.790

4.  Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.

Authors:  P H Chandrasekar; D P Levine; S Price; M J Rybak
Journal:  J Antimicrob Chemother       Date:  1988-04       Impact factor: 5.790

5.  Combinations of cefoxitin plus other β-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus.

Authors:  R Banerjee; M G Fernandez; N Enthaler; C Graml; K E Greenwood-Quaintance; R Patel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-23       Impact factor: 3.267

6.  Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.

Authors:  Thomas J Dilworth; Jora Sliwinski; Keenan Ryan; Monique Dodd; Renée-Claude Mercier
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

7.  Disruption of allosteric response as an unprecedented mechanism of resistance to antibiotics.

Authors:  Jennifer Fishovitz; Alzoray Rojas-Altuve; Lisandro H Otero; Matthew Dawley; Cesar Carrasco-López; Mayland Chang; Juan A Hermoso; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2014-07-02       Impact factor: 15.419

8.  Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.

Authors:  Patrick R Gonzales; Mitchell W Pesesky; Renee Bouley; Anna Ballard; Brent A Biddy; Mark A Suckow; William R Wolter; Valerie A Schroeder; Carey-Ann D Burnham; Shahriar Mobashery; Mayland Chang; Gautam Dantas
Journal:  Nat Chem Biol       Date:  2015-09-14       Impact factor: 15.040
  8 in total
  3 in total

1.  Raf-kinase inhibitor GW5074 shows antibacterial activity against methicillin-resistant Staphylococcus aureus and potentiates the activity of gentamicin.

Authors:  Tatiana Johnston; Gabriel Lambert Hendricks; Steven Shen; Roy Fangxing Chen; Bumsup Kwon; Michael John Kelso; Wooseong Kim; Beth Burgwyn Fuchs; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2016-09-21       Impact factor: 3.808

Review 2.  β-Lactam Resistance Mechanisms: Gram-Positive Bacteria and Mycobacterium tuberculosis.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

3.  Aspermerodione, a novel fungal metabolite with an unusual 2,6-dioxabicyclo[2.2.1]heptane skeleton, as an inhibitor of penicillin-binding protein 2a.

Authors:  Yuben Qiao; Xiaotian Zhang; Yan He; Weiguang Sun; Wenya Feng; Junjun Liu; Zhengxi Hu; Qianqian Xu; Hucheng Zhu; Jinwen Zhang; Zengwei Luo; Jianping Wang; Yongbo Xue; Yonghui Zhang
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.